JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2012, Vol. 50 ›› Issue (3): 17-.

• Articles • Previous Articles     Next Articles

Preparation and bioactivity characterization of recombinant
human soluble mutant BAFF

LI Hong-chang1, JIAO Yu-lian2, CUI Bin2, LIU Xiao-wen2, LU Bing-ru2, SUN Wen-ping2,
 SUN Ya-fang1, LIU Xiang-dong3, ZHAO Yue-ran1,2   

  1. 1. Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China; 
    2. Central Laboratory, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China; 
    3. Department of Clinical Laboratory, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China
  • Received:2011-10-27 Online:2012-03-10 Published:2012-03-10

Abstract:

 Objective   To prepare highly purified human soluble mutant B cell activating factor (smBAFF) and study its biological activity. Methods   Expression of the recombinant human smBAFF in E.coli BL21 was induced by IPTG, and the protein was assayed by SDS-PAGE and Western blot. The bacteria were split by sonication, inclusion bodies were extracted and dissolved, and then the smBAFF was purified by Ni2+-NTA affinity chromatography. The purified protein was refolded under specified conditions, and the bioactivity of the protein was assayed by immunofluorescence and CCK-8. Results   SDS-PAGE electrophoreses displayed that 1.7×104  recombinant protein was expressed, and Western blot showed that it was the protein of interest. The highly purified protein of the recombinant human smBAFF was attained by Ni2+-NTA affinity chromatography, and the recombinant protein could bind B cells, but lost the activity of co-stimulating B cell proliferation. Also, it could competitively inhibit the function of the soluble BAFF. Conclusions   The recombinant smBAFF was successfully prepared and possesses B cell binding activity but lost the activity of co-stimulating B cell proliferation. The result may lay a foundation to study the therapy for B cell malignancies and B cell abnormal activity diseases.

Key words: B cell activating factor belonging to the TNF family; Prokaryotic cells; Inclusion Bodies; Protein renaturation

CLC Number: 

  • R392.12
[1] LIANG Wei1, HOU Meng2, SONG Hui3. The carbon monoxide releasing molecule inhibits expression of vascular cell adhesion molecule under inflammatory conditions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(10): 33-37.
[2] LIU Lu1, ZHANG Wen1, CHEN Han-xiang1, ZHENG Lin1, LU Yi2,WANG Hong1, TANG Wei1, ZHAO Wei-ming1. Inflammatory responses of PGRN-deficient peritoneal macrophage to bacterial lipopolysaccharide in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 58-62.
[3] SUN Ya-fang1, WANG Yin-chang2, WANG Lai-cheng3, JIAO Yu-lian3, CUI Bin3, XIA Yu3, LU Bing-ru3, ZHAO Yue-ran1,3. Mutation analysis of SQSTM1 and TNFRSF11A genes in
a Chinese family with Paget disease of bone
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(12): 107-113.
[4] ZHU Yue-ting1, JIAO Yu-lian2, CUI Bin2, ZHANG Jie2, YOU Li2, ZHAO Yue-ran1,2. Expression of the fusion protein of human soluble B lymphocyte stimulator  and diphtheria toxin in E.coli and its biological activity [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 48-52.
[5] MENG Jing1,LIU Xiao-li2,GUO Chun3,MA Chun-hong3. Construction of the mouse T cell immunoglobulin mucin 3(Tim-3) eukaryotic expression vector [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(11): 37-40.
[6] . Construction of eukaryotic expression vectors of human HMGB1 and its expression in monocytes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(12): 61-65.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!